In an animal study, Sun and his colleagues found that Rehmannioside A could attenuate cognitive deficits in rats with VD through reducing the release of proinflammatory cytokines, including TNF-α, IL-1β, and IL-6 [20]. This evidence concerns the gene TNF and Cognitive impairment.